StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

<< Previous

Bullboard Posts

Next >>

Post by LithLoveron Feb 17, 2023 12:49pm

243 Views

Post# 35292377

METRICS - Posted a couple hours ago on LinkedIn

StageZero's Care Oncology is in discussions with leading cancer centers in London, UK and Toronto, Canada to expand the original METRICS study (METRICS II) using the new tools available in the next generation COC Protocol. Early discussions include looking at glioblastoma patients earlier in the course of their disease, tracking metabolic syndrome and inflammation through blood biomarker tests, and introducing neuroimaging to track progress in tumors while on the protocol. https://ow.ly/keNT50MTytz

graphical user interface, text, application